Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma

por Oosting, Sjoukje F., Haddad, Robert I.
Publicado 2019

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell ca...

por Machiels, Jean-Pascal H, Licitra, Lisa F, Haddad, Robert I, Tahara, Makoto, Cohen, Ezra EW
Publicado 2014

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients

por Sridharan, Vishwajith, Margalit, Danielle N., Lynch, Stephanie A., Severgnini, Mariano, Hodi, F. Stephen, Haddad, Robert I., Tishler, Roy B., Schoenfeld, Jonathan D.
Publicado 2016

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

por Haddad, Robert I., Schlumberger, Martin, Wirth, Lori J., Sherman, Eric J., Shah, Manisha H., Robinson, Bruce, Dutcus, Corina E., Teng, Angela, Gianoukakis, Andrew G., Sherman, Steven I.
Publicado 2017

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer

por Sridharan, Vishwajith, Margalit, Danielle N, Lynch, Stephanie A, Severgnini, Mariano, Zhou, Jun, Chau, Nicole G, Rabinowits, Guilherme, Lorch, Jochen H, Hammerman, Peter S, Hodi, F Stephen, Haddad, Robert I, Tishler, Roy B, Schoenfeld, Jonathan D
Publicado 2016

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

por Hanna, Glenn J., Rettig, Eleni M., Park, Jong C., Varvares, Mark A., Lorch, Jochen H., Margalit, Danielle N., Schoenfeld, Jonathan D., Tishler, Roy B., Goguen, Laura A., Annino, Donald J., Haddad, Robert I., Uppaluri, Ravindra
Publicado 2021

Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia

por Hanna, Glenn J., Villa, Alessandro, Mistry, Nikhil, Jia, Yonghui, Quinn, Charles T., Turner, Madison M., Felt, Kristen D., Pfaff, Kathleen, Haddad, Robert I., Uppaluri, Ravindra, Rodig, Scott J., Woo, Sook-Bin, Egloff, Ann Marie, Hodi, F. Stephen
Publicado 2021

Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia

por Hanna, Glenn J., Villa, Alessandro, Mistry, Nikhil, Jia, Yonghui, Quinn, Charles T., Turner, Madison M., Felt, Kristen D., Pfaff, Kathleen, Haddad, Robert I., Uppaluri, Ravindra, Rodig, Scott J., Woo, Sook-Bin, Egloff, Ann Marie, Hodi, F. Stephen
Publicado 2022

An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients

por Chau, Nicole G, Ma, Clement, Danga, Kristina, Al-Sayegh, Hasan, Nardi, Valentina, Barrette, Ryan, Lathan, Christopher S, DuBois, Steven G, Haddad, Robert I, Shapiro, Geoffrey I, Sallan, Stephen E, Dhar, Arindam, Nelson, Jeanenne J, French, Christopher A
Publicado 2019

Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer

por Rabinowits, Guilherme, Bowden, Michaela, Flores, Ludmila M., Verselis, Sigitas, Vergara, Victoria, Jo, Vickie Y., Chau, Nicole, Lorch, Jochen, Hammerman, Peter S., Thomas, Tom, Goguen, Laura A., Annino, Donald, Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Haddad, Robert I.
Publicado 2017

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

por Haddad, Robert I, Seiwert, Tanguy Y, Chow, Laura Q M, Gupta, Shilpa, Weiss, Jared, Gluck, Iris, Eder, Joseph P, Burtness, Barbara, Tahara, Makoto, Keam, Bhumsuk, Kang, Hyunseok, Muro, Kei, Albright, Andrew, Mogg, Robin, Ayers, Mark, Huang, Lingkang, Lunceford, Jared, Cristescu, Razvan, Cheng, Jonathan, Mehra, Ranee
Publicado 2022

Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline

por Ye, Zezhong, Saraf, Anurag, Ravipati, Yashwanth, Hoebers, Frank, Zha, Yining, Zapaishchykova, Anna, Likitlersuang, Jirapat, Tishler, Roy B., Schoenfeld, Jonathan D., Margalit, Danielle N., Haddad, Robert I., Mak, Raymond H., Naser, Mohamed, Wahid, Kareem A., Sahlsten, Jaakko, Jaskari, Joel, Kaski, Kimmo, Mäkitie, Antti A., Fuller, Clifton D., Aerts, Hugo J.W.L., Kann, Benjamin H.
Publicado 2023

Biomarkers predictive of response to pembrolizumab in head and neck cancer

por Pfister, David G., Haddad, Robert I., Worden, Francis P., Weiss, Jared, Mehra, Ranee, Chow, Laura Q. M., Liu, Stephen V., Kang, Hyunseok, Saba, Nabil F., Wirth, Lori J., Sukari, Ammar, Massarelli, Erminia, Ayers, Mark, Albright, Andrew, Webber, Andrea L., Mogg, Robin, Lunceford, Jared, Huang, Lingkang, Cristescu, Razvan, Cheng, Jonathan, Seiwert, Tanguy Y., Bauml, Joshua M.
Publicado 2022

Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer

por Ye, Zezhong, Saraf, Anurag, Ravipati, Yashwanth, Hoebers, Frank, Catalano, Paul J., Zha, Yining, Zapaishchykova, Anna, Likitlersuang, Jirapat, Guthier, Christian, Tishler, Roy B., Schoenfeld, Jonathan D., Margalit, Danielle N., Haddad, Robert I., Mak, Raymond H., Naser, Mohamed, Wahid, Kareem A., Sahlsten, Jaakko, Jaskari, Joel, Kaski, Kimmo, Mäkitie, Antti A., Fuller, Clifton D., Aerts, Hugo J. W. L., Kann, Benjamin H.
Publicado 2023

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

por Haddad, Robert I., Harrington, Kevin, Tahara, Makoto, Ferris, Robert L., Gillison, Maura, Fayette, Jerome, Daste, Amaury, Koralewski, Piotr, Zurawski, Bogdan, Taberna, Miren, Saba, Nabil F., Mak, Milena, Kawecki, Andrzej, Girotto, Gustavo, Alvarez Avitia, Miguel Angel, Even, Caroline, Toledo, Joaquin Gabriel Reinoso, Guminski, Alexander, Müller-Richter, Urs, Kiyota, Naomi, Roberts, Mustimbo, Khan, Tariq Aziz, Miller-Moslin, Karen, Wei, Li, Argiris, Athanassios
Publicado 2023

Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial

por Hanna, Glenn J., Villa, Alessandro, Nandi, Shuvro P., Shi, Ruichao, ONeill, Anne, Liu, Mofei, Quinn, Charles T., Treister, Nathaniel S., Sroussi, Herve Y., Vacharotayangul, Piamkamon, Goguen, Laura A., Annino, Donald J., Rettig, Eleni M., Jo, Vickie Y., Wong, Kristine S., Lizotte, Patrick, Paweletz, Cloud P., Uppaluri, Ravindra, Haddad, Robert I., Cohen, Ezra E. W., Alexandrov, Ludmil B., William, William N., Lippman, Scott M., Woo, Sook-bin
Publicado 2023

Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study

por Schmidt, Andrew L., Bakouny, Ziad, Bhalla, Sheena, Steinharter, John A., Tremblay, Douglas A., Awad, Mark M., Kessler, Alaina J., Haddad, Robert I., Evans, Michelle, Busser, Fiona, Wotman, Michael, Curran, Catherine R., Zimmerman, Brittney S., Bouchard, Gabrielle, Jun, Tomi, Nuzzo, Pier V., Qin, Qian, Hirsch, Laure, Feld, Jonathan, Kelleher, Kaitlin M., Seidman, Danielle, Huang, Hsin-Hui, Anderson-Keightly, Heather M., Abou Alaiwi, Sarah, Rosenbloom, Talia D., Stewart, Penina S., Galsky, Matthew D., Choueiri, Toni K., Doroshow, Deborah B.
Publicado 2020

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

por Hanna, Glenn J., O'Neill, Anne, Shin, Kee-Young, Wong, Kristine, Jo, Vickie Y., Quinn, Charles T., Cutler, Jennifer M., Flynn, Michelle, Lizotte, Patrick H., Annino, Donald J., Goguen, Laura A., Kass, Jason I., Rettig, Eleni M., Sethi, Rosh K.V., Lorch, Jochen H., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Everett, Peter C., Desai, Anupam M., Cavanaugh, Megan E., Paweletz, Cloud P., Egloff, Ann Marie, Uppaluri, Ravindra, Haddad, Robert I.
Publicado 2022

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

por Miao, Diana, Margolis, Claire A., Vokes, Natalie I., Liu, David, Taylor-Weiner, Amaro, Wankowicz, Stephanie M., Adeegbe, Dennis, Keliher, Daniel, Schilling, Bastian, Tracy, Adam, Manos, Michael, Chau, Nicole G., Hanna, Glenn J., Polak, Paz, Rodig, Scott J., Signoretti, Sabina, Sholl, Lynette M., Engelman, Jeffrey A., Getz, Gad, Jänne, Pasi A., Haddad, Robert I., Choueiri, Toni K., Barbie, David A., Haq, Rizwan, Awad, Mark M., Schadendorf, Dirk, Hodi, F. Stephen, Bellmunt, Joaquim, Wong, Kwok-Kin, Hammerman, Peter, Van Allen, Eliezer M.
Publicado 2018

Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study

por Bhalla, Sheena, Bakouny, Ziad, Schmidt, Andrew L., Labaki, Chris, Steinharter, John A., Tremblay, Douglas A., Awad, Mark M., Kessler, Alaina J., Haddad, Robert I., Evans, Michelle, Busser, Fiona, Wotman, Michael, Curran, Catherine R., Zimmerman, Brittney S., Bouchard, Gabrielle, Jun, Tomi, Nuzzo, Pier V., Qin, Qian, Hirsch, Laure, Feld, Jonathan, Kelleher, Kaitlin M., Seidman, Danielle, Huang, Hsin-Hui, Anderson-Keightly, Heather M., El Zarif, Talal, Abou Alaiwi, Sarah, Rosenbloom, Talia D., Stewart, Penina S., Galsky, Matthew D., Choueiri, Toni K., Doroshow, Deborah B.
Publicado 2021